Evoke Pharma, Inc. (EVOK:NASDAQ) soared at $3, representing a gain of 46.3%. On Wed, Jun 15, 2022, EVOK:NASDAQ hit a New 2-Week High of $3. The stock appeared on our News Catalysts scanner on Wed, Jun 15, 2022 at 09:30 AM in the 'MISCELLANEOUS' category. From Wed, Jun 01, 2022, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Apr 26, 2022 at $16.8 with a volume of 17M+.
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Sidus Space Inc. (SIDU:NASDAQ), 225%
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 46.34%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 41.92%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 41%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 40.38%
- AeroClean Technologies Inc. (AERC:NASDAQ), 37.59%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 32.46%
- MICT, Inc. (MICT:NASDAQ), 31.71%
- Austin Gold Corp. (AUST:NYSEMKT), 27.44%